We sought to analyze the relationship between uric acid (UA) and vascular structure and function based on the carotid intima-media thickness, the pulse-wave velocity (PWV), the central arterial pressure, and the augmentation index in hypertensive patients and to evaluate the sex-related differences.
Increased serum uric acid (UA) is generally associated with important risk factors for atherosclerosis, such as hypertension, 1,2 type 2 diabetes, 3 metabolic syndrome, 4, 5 abdominal obesity, renal failure, vascular disease (carotid, peripheral, coronary), inflammation markers (high-sensitivity C-reactive protein), and endothelial dysfunction. 4, [6] [7] [8] The relative importance of these associations remains controversial. Some experts, such as the Framingham Heart Study group, 9 have argued that UA is not a risk factor for cardiovascular disease and that clinicians should rely only on classical risk factors in patient assessment. The Genetic Epidemiology Network of Arteriopathy study 10 found UA to be associated with the presence and severity of coronary heart disease after adjusting for age and sex but not after further adjustment for cardiovascular risk factors. A review by Gagliardi et al. 6 concluded that there is strong evidence that, for most subjects, increased UA concentrations and gout are associated with subclinical atherosclerosis and an increased risk of cardiovascular events, especially in the presence of metabolic syndrome. However, other authors consider serum UA to be independently associated with the risk of cardiovascular mortality, 11 and prospective studies have demonstrated independent and significant associations between increased UA levels and cardiovascular events. 12, 13 Studies analyzing the relationship between UA and arterial stiffness have not yielded conclusive results. There are studies in the general population reporting an independent association, 14, 15 although Lim et al. 16 observed no such association. Some studies have reported an association in hypertensive patients 17, 18 between UA and the parameters used to assess arterial stiffness, whereas in other publications, this association disappears after adjusting for risk factors. 19 Regarding the relationship to sex, Ishizaka et al., 4 in their study of a large Japanese cohort, found increased UA levels to be associated with increased carotid atherosclerosis in men without metabolic syndrome. However, no association was found in either men with metabolic syndrome or women.
The relationship between UA and arterial stiffness and wave reflections in patients with diabetes mellitus and hypertension and the corresponding sex differences have not been defined.
This study analyzes the relationship between UA and vascular structure and function based on the carotid intimamedia thickness (C-IMT), the pulse-wave velocity (PWV), the central arterial pressure, and the augmentation index in hypertensive patients, and we also investigated the sexrelated differences.
Methods study design and population
Subjects were selected through consecutive sampling from 402 patients included in the Vasorisk study cohort 20 (Clinical Trials.gov Identifier: NCT01325064). Of these, 36 were excluded because of the absence of data on plasma UA or an assessment of the vascular structure and function. Therefore, this study analyzed 366 subjects (226 men and 140 women) aged 34-75 years who visited primary care clinics between January 2009 and June 2011. With these subjects and accepting an alpha risk of 0.05 in a 2-sided test, the study had a power of 80% for detecting a minimum correlation coefficient of 0.15 between UA and PWV in the global study population and minimum correlation coefficients of 0.19 in men and 0.24 in women. The study was approved by an independent ethics committee of Salamanca University Hospital (Spain), and all participants gave written informed consent according to the general recommendations of the Declaration of Helsinki.
Variables and measurement instruments
A detailed description has been published elsewhere of how the clinical data were collected and the analytical parameters were obtained. 20 
Anthropometric measurements.
Body weight was determined on 2 occasions using a homologated electronic scale (Seca770; Medical scale and measurement systems, Birmingham, Reino Unido) after calibration with the patient wearing light clothing and no shoes. Height was measured with a portable system (Seca222; Medical scale and measurement systems, Birmingham, Reino Unido) with the patient shoeless in the standing position; the average of 2 readings was recorded. Body mass index (BMI) was calculated as weight (kg) divided by height squared (m²). A value of > 30 kg/m² was taken to define obesity. Waist circumference was measured as follows: the upper margins of the iliac crests were located, and the tape was wrapped around the body above this point, parallel to the floor, ensuring that it was adjusted without compressing the skin. Normal readings were defined as <102 cm in men and <88 cm in women. 21 Laboratory determinations. Venous blood sampling was performed between 8:00 am and 9:00 am with the participants having fasted and abstained from smoking and consumption of alcohol and caffeinated beverages for the previous 12 hours. The blood samples were used for the determination of the complete blood count, creatinine, lipoprotein profile, blood glucose, gamma-glutamyl transpeptidase, high-sensitivity C-reactive protein, insulinemia, and UA. The estimated glomerular filtration rate was calculated based on the CKD-EPI formula for whites. 22 Insulin sensitivity was determined with the homeostasis model assessmentInsulin Resistance (IR) index using the following formula: fasting glucose (mmol/L) × fasting insulin (mU/ml)/22.5.
Office or clinical blood pressure measurement. Three measurements of systolic (SBP) and diastolic blood pressure (DBP) were performed, using the average of the last 2 measurements, with a validated OMRON model M10-IT sphygmomanometer (Omron Health Care, Kyoto, Japan), and following the recommendations of the European Society of Hypertension. Hypertension was defined as the presence of antihypertensive medication or when the mean of three recordings in the clinic, under basal condition and separated in time, was ≥140 mm Hg for SBP and/or ≥90 mm Hg for DBP.
Ambulatory blood pressure monitoring. Ambulatory blood pressure monitoring was performed on a day of standard activity, with an adequate cuff for the size of the patient's arm. A control system was used (Spacelabs 90207; Spacelabs Healthcare, Issaquah, WA). 23 The records of readings considered to be valid were ≥80% of the total. The monitor was programmed for obtaining blood pressure measurements every 20 minutes during the waking period and every 30 minutes during the resting period. Individual correction was made of the waking and sleeping hours reported by the patient. The ambulatory arterial stiffness index (AASI), which was used to evaluate vascular function, was defined as 1 minus the regression slope of the DBP over the SBP readings obtained from individual 24-hour blood pressure recordings. The stiffer the arterial tree, the closer the regression slope and AASI were to 0 and 1, respectively. 24 The blood pressure variability ratio (BPVR) was defined as SD (SBP)/SD (DBP), and AASI_BPVR as 1 − [1/SD (SBP)/ SD (DBP)] in reference to the 24-hour blood pressure. 25 Assessment of arterial stiffness, central arterial pressure, and hemodynamic parameters (PWV and peripheral augmentation index (PAIx) and central (CAIx) augmentation index). A SphygmoCor System (AtCor Medical, West Ryde, Australia) was used to measure the PWV and the PAIx and CAIx. Using the SphygmoCor System (Px Pulse Wave Analysis), with the patient in the sitting position and resting his or her arm on a rigid surface, pulse-wave analysis was performed with a sensor in the radial artery and using mathematical transformation to estimate the aortic pulse wave. The reliability of these measurements was evaluated before the study using the CAIx intraclass correlation coefficient, which showed values of 0.97 (95% confidence interval (CI) = 0.94-0.90) for intraobserver agreement on repeated measurements in 22 subjects. According to the BlandAltman analysis, the limit of the intraobserver agreement was 0.45 (95% CI = −9.88 to 10.79). From the morphology of the aortic wave, CAIx was estimated using the following formula: increase in central pressure ×100/pulse pressure. PAIx, in turn, was calculated as follows: (second peak SBP − DBP)/ (first peak SBP − DBP) × 100(%). Using the SphygmoCor System (V × PWV), with the patient in the supine position, the pulse wave of the carotid and femoral arteries was analyzed, estimating the delay with respect to the electrocardiogram wave and calculating the PWV. Distance measurements were taken with a measuring tape from the sternal notch to the carotid and femoral arteries at the sensor location. 21 Assessment of vascular structure based on the C-IMT. Carotid ultrasound to assess C-IMT was performed by 2 investigators who were trained for this purpose before starting the study. The reliability of the recordings was evaluated before the study using the intraclass correlation coefficient, which showed values of 0.97 (95% CI = 0.94-0.99) for intraobserver agreement on repeated measurements in 20 subjects and 0.90 (95% CI = 0.74-0.96) for interobserver agreement. According to the Bland-Altman analysis, the limit of interobserver agreement was 0.02 (95%CI = −0.05 to 0.10), whereas the limit of intraobserver agreement was 0.01 (95% CI = −0.03 to 0.06). A Sonosite Micromax ultrasound device paired with a 5-10 MHz multifrequency high-resolution linear transducer with Sonocal software was used for performing automatic measurements of C-IMT to optimize the reproducibility. Measurements were made of the common carotid after the examination of a 10-mm longitudinal section at a distance of 1 cm from the bifurcation, performing measurements in the anterior or proximal wall and in the posterior or distal wall in the lateral, anterior, and posterior projections following an axis perpendicular to the artery to discriminate 2 lines: one for the intima-blood interface and the other for the media-adventitious interface. Six measurements of the right carotid and another 6 measurements of the left carotid were obtained using average values (average C-IMT) and maximum values (maximum C-IMT) automatically calculated by the software. 26 The measurements were obtained with the subject lying down, with the head extended and slightly turned opposite to the examined carotid artery. The average C-IMT was considered abnormal if it measured 0.90 mm or if there were atherosclerotic plaques with a diameter of 1.5 mm or a focal increase of 0.5 mm or 50% of the adjacent C-IMT. 21 Evaluation of peripheral artery involvement. Peripheral artery involvement was assessed using the ankle-brachial index and recorded in the morning after the participants had abstained from the consumption of coffee or tobacco for at least 8 hours before measurement and at a room temperature of 22-24 °C. With the feet uncovered, in supine decubitus, and after 20 minutes of rest, the blood pressure in the lower extremities and the pressure in both arms were measured using a portable WatchBP Office ankle-brachial index (Microlife AG Swiss Corporation Espenstrasse 139. CH-9443 Widnau/ Switzerland). The ankle-brachial index was calculated automatically for each foot by dividing the higher of the 2 systolic pressures in the ankle by the highest measurement of the two systolic pressures in the arm. An ankle-brachial index < 0.9 was considered abnormal. 21 Cardiovascular risk assessment. The risk of cardiovascular morbidity and mortality was estimated using the published risk equation of the D' Agostino scale. 27 The individuals performing the different tests were blinded to the clinical data of the patient. All organ damage assessments were made within a period of 10 days.
statistical analysis
Statistical normality was checked using the KolmogorovSmirnov test. Normally distributed continuous variables were expressed as the mean ± SD, whereas nonnormally distributed variables were presented as the median and interquartile range, with log transformation for analyses. Frequency distributions were used in the case of qualitative variables. Comparison between the quantitative variables was performed using the Student t test or Mann-Whitney U test as appropriate, whereas the χ 2 test was used to compare the qualitative variables. The Pearson or Spearman correlation coefficient was used to estimate the relationship between the quantitative variables, whereas the χ 2 test was used to associate the qualitative variables. Multiple linear regression analysis was performed using waist circumference, CAIx, maximum C-IMT, and AASI as dependent variables and UA as an independent variable. The analysis was performed overall and by sex, establishing three models: a first model without adjustment; a second model that included age, sex, SBP, blood glucose, high-density lipoprotein cholesterol, and smoking as the adjustment variables; and a third model that added estimated glomerular filtration rate, waist circumference, high-sensitivity C-reactive protein, and diuretics. To obtain values larger than 1 and facilitate the interpretation, the AASI values were multiplied by 10. The data were analyzed using the SPSS version 18.0 statistical package (SPSS, Chicago, IL). A value of P < 0.05 was considered statistically significant.
results
The demographic and clinical characteristics of the participants, globally and according to sex, are shown in Table 1 . UA, waist circumference, percentage smokers, alcohol intake, and gamma-glutamyl transpeptidase were higher in men. However, percentage abdominal obesity and high-density lipoprotein cholesterol were higher in women. Table 2 shows the arterial structure and function indices and the 10-year cardiovascular disease risk globally and by sex. The ankle-brachial index, the mean and maximum C-IMT, the percentage atherosclerotic plaques, and the 10-year cardiovascular disease risk were higher in men. However, CAIx, PAIx, and AASI were higher in women. The mean and maximum C-IMT and the percentage atherosclerotic plaques were higher in the third tertile of UA (P < 0.05). CAIx and PAIx decreased with increasing UA tertiles (P < 0.05). The remaining variables used to assess vascular structure and function showed no differences when analyzed according to the UA tertiles. Figure 1 shows the behavior of the PWV and CAIx in men and women according to UA tertiles. BMI, waist circumference, triglycerides, high-sensitivity C-reactive protein, and the homeostasis model assessment index were positively correlated with UA for both sexes. PWV and AASI were positively correlated with UA only in women. In turn, CAIx and PAIx were negatively correlated with UA only in the global analysis. The correlations were not modified when those patients with diuretic treatment were excluded from the analysis ( Table 3) .
The overall multiple linear regression analysis (Table 4 ) showed a significant positive association between PWV and UA levels after adjusting for age and classical risk factors (smoking, SBP, blood glucose levels, and cholesterol levels) (β = 0.15; P < 0.03). However, this association lost significance after adjusting for confounders in model 3 (β = 0.73; P = 0.13). There were no significant associations between IMT, CAIx, or AASI and UA levels.
In the sex-specific multiple linear regression analysis (Table 4) , only women showed a significant positive association between PWV and UA levels after adjusting for age and classical risk factors (β = 0.27; P = 0.01). However, this association lost significance after adjusting for confounders in model 3. A significant negative association was observed between AASI and UA levels after adjusting for confounders in model 3 among men (β = −0.06; P = 0.04), with a positive association in women (β = 0.11; P = 0.03). Regarding wave reflections, UA was not correlated with the augmentation index in either sex.
discussion
The results of this study indicate that serum UA is positively correlated with the mean maximum IMT and PWV and negatively correlated with CAIx and PAIx, although this association is lost after adjusting for confounding factors. In turn, UA shows a positive association with AASI in women and a negative association in men after adjusting for confounding factors.
Our results expand the current knowledge on the association between UA and the different parameters used to assess vascular structure and function, which are limited to studies in the general population, healthy, young subjects, and untreated hypertensive patients. In Japanese individuals, UA was associated with an increase in arterial stiffness, as estimated by the ankle-brachial PWV. 15 However, in Korean adults, 16 UA was not associated with PWV in either men or women. In young, healthy individuals, a correlation between UA levels and echocardiographic indices of arterial stiffness was reported. 28 The effect of UA levels upon arterial stiffness in never-treated hypertensive subjects was found to be independent of factors that influence the PWV in both sexes. 17 The results of this study on hypertensive and diabetic patients only reflect this association after adjusting for classical risk factors (smoking, blood glucose, cholesterol, and hypertension). Moreover, the association was lost in women after adjusting for other confounding factors (variables related to weight, renal function, and treatment with diuretics). Therefore, based on the available data, UA Continuous variables are presented as mean ± SD or median (interquartile range). Abbreviations: AASI, ambulatory arterial stiffness index; BPVR, blood pressure variability ratio (calculated by the general cardiovascular risk profile algorithm proposed by the Framingham Heart Study group in those aged 30-74 years); CAIx, central augmentation index corrected for heart rate; cfPWV, carotid-femoral pulse-wave velocity; CVD, cardiovascular; DBP, diastolic blood pressure; IMT, intima-media thickness; PAIx, peripheral augmentation index; PP, pulse pressure; SBP, systolic blood pressure.
cannot be regarded as an independent risk factor for arterial stiffness as assessed by PWV. Although the results differ according to the population studied, the adjustments made for other confounding factors in different studies vary, and this fact, as well as the specific characteristics of each group, most likely accounts for these discrepancies.
Wave reflections, estimated by CAIx and PAIx, showed an inverse correlation with UA in the global analysis. Vlachopoulos et al. 17 found similar results in newly diagnosed hypertensive patients, but only in women. In this study, the association between UA and CAIx and PAIx was lost after adjusting for other risk factors.
The negative relationship between UA and CAIx and PAIx, in contrast to its relationship to PWV, is surprising and can most likely be explained by a number of factors, such as the fact that the augmentation index is a composite index that integrates the amount of the wave that is reflected back to the aorta (depending on the tone of the resistance arteries, which are the main peripheral reflecting sites) and the velocity of the incident and reflected wave (which in turn depends on the arterial stiffness). 29 Augmentation index values decrease as BMI increases, 30 and UA is higher in subjects with a greater BMI; accordingly, BMI may be a confounding factor in this negative correlation between UA and CAIx and PAIx.
In this study, AASI showed a significant negative correlation with UA levels after adjusting for confounders in men, and a positive correlation was observed in women. To our knowledge, no studies have analyzed this association, and prospective studies are therefore needed to confirm these findings. Dependent variables: carotid Intima-media thickness maximum, pulse-wave velocity, central augmentation index, and ambulatory arterial stiffness index.
Model 1: Unadjusted. Model 2: Adjusted for age, sex (men = 1; women = 0), systolic blood pressure, glucose, ln high-density lipoprotein cholesterol, smokers. Model 3: Adjusted for age, sex (men = 1; women = 0), systolic blood pressure, glucose, ln high-density lipoprotein cholesterol, smokers, estimated glomerular filtration rate, waist circumference, ln high-sensitivity C-reactive protein, diuretics, losartan, and statins.
Abbreviation: CI, confidence interval. Abbreviations: AASI, ambulatory arterial stiffness index; BMI, body mass index; CAIx, central augmentation index; DBP, diastolic blood pressure; eGFR, estimated glomerular filtration rate; HOMA, homeostasis model assessment; hsCRP, high-sensitivity C-reactive protein; PAIx, peripheral augmentation index; PP, pulse pressure; PWV, pulse-wave velocity; SBP, systolic blood pressure. *P < 0.05; **P < 0.01.
Serum UA is correlated with the maximum IMT, but this association loses its significance in both sexes after adjustment for other risk factors. A cross-sectional evaluation of the Atherosclerosis Risk in Communities study population in whites and blacks in the United States showed serum UA to be associated with IMT in both men and women. 31 However, this association lost its significance in women and decreased in men after adjusting for other risk factors. Consequently, our data support the conclusion drawn by Gagliardi. 6 So far, there is strong evidence that for most subjects increased UA concentrations and gout are associated with subclinical atherosclerosis.
The results obtained in our study are consistent with those reported by Cipolli et al. 32 on a sample of 348 hypertensive patients in which the relationship between UA and carotid structural and hemodynamic parameters was investigated. Given that the C-IMT was the only common parameter analyzed in both studies, neither study observed a relationship between C-IMT and plasma UA. This study identified a positive correlation with the internal carotid artery resistive index (r = 0.34; P < 0.01) in women but not in men (r = −0.11; P > 0.05). These data agree with those obtained in our study, where a positive correlation was identified between UA and AASI in women (r = 0.25; P < 0.01) but not in men (r = −0.02; P > 0.05). This concordance could be explained by the fact that both studies use hemodynamic parameters (systolic and diastolic velocities in the internal carotid artery resistive index and 24-hour SBP and DBP in the AASI). The observation of this positive association in women and negative association in men will require confirmation with future studies.
Some study limitations should be considered in the interpretation of our results. Because this was a cross-sectional, observational study, the results do not infer causality. Our study population consisted solely of white subjects, so the observed associations may not be applicable to other ethnic groups. When interpreting the results, we also must take into account that the groups of men and women might not be comparable and the inclusion of hypertensive patients treated with different drugs might influence the results.
This study shows UA to be positively correlated with mean maximum C-IMT and PWV and negatively correlated with CAIx and PAIX, although this association is lost after adjusting for confounding factors. UA shows a positive association with the AASI in women and a negative association in men after adjusting for confounding factors.
Further research involving prospective/intervention studies is required to establish whether arterial function mediates the relationship between this molecule and the parameters used to assess vascular structure and function. In addition, possible sex-specific roles of UA remain to be elucidated. 
